MedPath

A clinical trial to evaluate the efficacy of three different indirect pulp capping agents, Silver diamine fluoride, Biodentine and Calcium hydroxide in primary molars.

Not Applicable
Registration Number
CTRI/2023/09/057227
Lead Sponsor
Dr VidyaS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) All healthy children within the age range of 6-9 years of both sexes.

2) Co-operative children with Frankel behavior rating scale (FBRS) score of 3 or 4.

3) Patient with history of tolerable, dull, intermittent pain, mild discomfort associated with eating.

4) On clinical examination, carious lesion involving occlusal surface of the maxillary and mandibular primary molars with normal appearance of gingiva.

5) Radiographic examination showing carious lesions approximating the pulp.

6) Normal lamina dura, normal PDL space, more than 2/3rd of root present, no periapical changes, no pathological external/internal resorption

Exclusion Criteria

1) Subjects under medications for analgesics and antibiotics.

2) Primary molar near exfoliation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Clinical success <br/ ><br>2) Radiographic successTimepoint: 6 and 12 months follow up
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath